ArticleCancers2022

Molecular Characterization Reveals Subclasses of 1q Gain in Intermediate Risk Wilms Tumors.

Ianthe A E M van Belzen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.